Laserfiche WebLink
3.3 Testing laboratory - Medtox shall conduct an actual analysis of the specimen , <br /> provided by the collection site/clinic, using an immunochemical method, to <br /> determine the presence or absence of the following drugs: <br /> 3.3.1 Marijuana <br /> 3.31 Cocaine <br /> 3.3.3 Amphetamines <br /> 3.3.4 Opiates <br /> 3.3.5 Phencyclidine (PCP). <br /> At the request of the Member,Medtox shall screen for additional drugs. <br /> Medtox will automatically confirm by Gas ChroasatographyftA&u <br /> Spectrometry'(GCJMS) ag presumptive positive results fitom screening of <br /> the drugs awned above. The level at which a positive remult is confirmed <br /> shall be according to SAMHSA standards for the respective drugs. Medtox <br /> will report ali teat remb to the dedo naiad Me ed Review Officer within <br /> saventy-two(72)hours of receipt of the urine specimen. AD results wU be <br /> reported either negative or positive without mu ndc al values <br /> 3.4 Chain of CssWdy--Medtox shall maintain proper chain ofwatody controls <br /> duriag.ali testing and/or handling of urine specimens and proper chain of <br /> custody do tmnntation. Medtoxwm retain custody ofaey oohed <br /> podthl specimens tmderproper chain ofeustodyw d secured itch kmsted <br /> conditioa u per SAM SA regulation& <br /> 4 <br />